Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
News
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/8c/8a/ea/8c8aeae5-92cf-9ee8-0904-b47ef124d2c1/mza_14530798582758416436.jpg/600x600bb.jpg
BodyLab
QIMR Berghofer
53 episodes
1 week ago
Get ready for a remarkable journey through nearly four decades of iron metabolism research, from ground-breaking discoveries in liver disease to unforgettable lab stories involving a gel disaster and the QIMR Berghofer resident goose. Professor Greg Anderson reflects on mentorship, scientific breakthroughs, and the vibrant culture of QIMR Berghofer. Plus, hear about why science is as much about people as it is about data. A wonderful celebration of curiosity, collaboration and the...
Show more...
Health & Fitness
Medicine,
Science,
Life Sciences
RSS
All content for BodyLab is the property of QIMR Berghofer and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Get ready for a remarkable journey through nearly four decades of iron metabolism research, from ground-breaking discoveries in liver disease to unforgettable lab stories involving a gel disaster and the QIMR Berghofer resident goose. Professor Greg Anderson reflects on mentorship, scientific breakthroughs, and the vibrant culture of QIMR Berghofer. Plus, hear about why science is as much about people as it is about data. A wonderful celebration of curiosity, collaboration and the...
Show more...
Health & Fitness
Medicine,
Science,
Life Sciences
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/8c/8a/ea/8c8aeae5-92cf-9ee8-0904-b47ef124d2c1/mza_14530798582758416436.jpg/600x600bb.jpg
World-first clinical trial to test promising new approach to target triple-negative breast cancer
BodyLab
25 minutes
9 months ago
World-first clinical trial to test promising new approach to target triple-negative breast cancer
Metastatic triple-negative breast cancer has limited treatment options and is commonly diagnosed in younger women, aged under 40. But a promising combination therapy could offer a new approach to target this highly aggressive and treatment-resistant type of breast cancer. QIMR Berghofer Professor Sudha Rao and Kazia Therapeutics CEO Dr John Friend share the incredible story that led to their collaboration, and a world-first clinical trial.
BodyLab
Get ready for a remarkable journey through nearly four decades of iron metabolism research, from ground-breaking discoveries in liver disease to unforgettable lab stories involving a gel disaster and the QIMR Berghofer resident goose. Professor Greg Anderson reflects on mentorship, scientific breakthroughs, and the vibrant culture of QIMR Berghofer. Plus, hear about why science is as much about people as it is about data. A wonderful celebration of curiosity, collaboration and the...